GSK's phase 3 trials ANCHOR-1 and ANCHOR-2 met co-primary endpoints for treating CRSwNP with depemokimab. Adverse event rates were similar between depemokimab and placebo in the trials. Ready to turn ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--Aerin Medical Inc., a company that provides Ear, Nose and Throat (ENT) physicians with non-invasive solutions to treat chronic nasal conditions, today announced ...
That constant feeling of struggling to get enough air through your nose isn’t just annoying anymore. It’s affecting your sleep, your energy levels, and your overall quality of life. What started as ...
Given your nose’s front-and-center position on your face, it can be susceptible to injuries. Nose and nasal injuries can range from minor ones that can be treated at home to more serious issues that ...
Picture this: You wake up feeling groggy, stuffed up even after having an early night, or you wake up with a persistent headache despite a whole night’s rest, assuming it’s just a cold or stress.
The dreaded stuffy nose – that uncomfortable pressure and congestion that makes every breath a chore and every night’s sleep an exercise in frustration. But is it just seasonal allergies acting up, or ...
Please provide your email address to receive an email when new articles are posted on . 45.2% of patients who had “nasal allergies” had chronic rhinosinusitis. Patients with CRS tended to be older ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Scores on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback